|
BE794362A
(fr)
|
1972-01-22 |
1973-07-23 |
Merck Patent Gmbh |
Sulfates hydrosolubles de sterine
|
|
US3928397A
(en)
|
1973-03-02 |
1975-12-23 |
Eisai Co Ltd |
New 5-cholestene derivatives and preparation thereof
|
|
US3822254A
(en)
|
1973-05-21 |
1974-07-02 |
Hoffmann La Roche |
Synthesis of 25-hydroxycholesterol
|
|
US4264512A
(en)
|
1975-09-29 |
1981-04-28 |
The Regents Of The University Of California |
3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
|
|
US4049803A
(en)
|
1976-04-26 |
1977-09-20 |
Bristol-Myers Company |
Augmentation of blood levels of aspirin
|
|
CA1083044A
(en)
|
1976-05-04 |
1980-08-05 |
Stewart Wong |
Antiarthritic potentiation
|
|
US4202891A
(en)
|
1977-05-16 |
1980-05-13 |
Kandutsch Andrew A |
15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
|
|
GB1595020A
(en)
|
1977-06-24 |
1981-08-05 |
Chugai Pharmaceutical Co Ltd |
3a-hydroxy steroid derivatives of the cholestane series
|
|
US4233314A
(en)
|
1978-12-18 |
1980-11-11 |
Mcneilab, Inc. |
Analgesic potentiation
|
|
US4233315A
(en)
|
1978-12-18 |
1980-11-11 |
Mcneilab, Inc. |
Analgesic potentiation
|
|
US4233317A
(en)
|
1978-12-18 |
1980-11-11 |
Mcneilab, Inc. |
Analgesic potentiation
|
|
US4207340A
(en)
|
1978-12-18 |
1980-06-10 |
Mcneilab, Inc. |
Analgesic potentiation
|
|
US4233313A
(en)
|
1978-12-18 |
1980-11-11 |
Mcneilab, Inc. |
Analgesic potentiation
|
|
US4234601A
(en)
|
1978-12-18 |
1980-11-18 |
Mcneilab, Inc. |
Analgesic potentiation
|
|
US4242353A
(en)
|
1978-12-18 |
1980-12-30 |
Mcneilab, Inc. |
Analgesic potentiation
|
|
US4233316A
(en)
|
1978-12-18 |
1980-11-11 |
Mcneilab, Inc. |
Analgesic potentiation
|
|
US4237140A
(en)
|
1979-05-18 |
1980-12-02 |
E. I. Du Pont De Nemours And Company |
Analgesic mixture of nalbuphine and acetaminophen
|
|
US4260629A
(en)
|
1979-10-25 |
1981-04-07 |
E. I. Du Pont De Nemours And Company |
Treating pain with acetaminophen and 1,4-dimethyl-5-p-chlorobenzoyl-pyrrole-2-acetic acid
|
|
US4314989A
(en)
|
1980-05-07 |
1982-02-09 |
Rosen Gerald M |
Methionine sulfoxide amflioration of acetaminophen toxicity
|
|
US4307073A
(en)
|
1980-08-08 |
1981-12-22 |
The Research Foundation Of State University Of New York |
Method and composition for reducing the toxicity of acetaminophen
|
|
US4401665A
(en)
|
1981-04-14 |
1983-08-30 |
Bristol-Myers Company |
Sleep-aid composition containing an analgesic and diphenhydramine dihydrogencitrate, and method of use
|
|
US4460368A
(en)
|
1981-10-29 |
1984-07-17 |
Almedco, Inc. |
Trans-dermal medication system
|
|
US4427668A
(en)
|
1982-04-01 |
1984-01-24 |
New York University |
26-Hydroxycholesterol and derivatives and analogs thereof in regulation of cholesterol accumulation in body tissue
|
|
US4794112A
(en)
|
1982-12-09 |
1988-12-27 |
Cooper Stephen A |
Acetaminophen/hydroxyzine analgesic combinations
|
|
US4478822A
(en)
|
1983-05-16 |
1984-10-23 |
Merck & Co., Inc. |
Drug delivery system utilizing thermosetting gels
|
|
US4476115A
(en)
|
1983-07-05 |
1984-10-09 |
Reed Raymond E |
Analgesic composition and method of treating subdermal pain
|
|
GB8325627D0
(en)
|
1983-09-24 |
1983-10-26 |
Scras |
Therapeutic compositions
|
|
US4466960A
(en)
|
1983-10-18 |
1984-08-21 |
Thompson Medical Co., Inc. |
Analgesic-diuretic compositions
|
|
US4681897A
(en)
|
1984-01-16 |
1987-07-21 |
The Procter & Gamble Company |
Pharmaceutical products providing enhanced analgesia
|
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
|
US4730007A
(en)
|
1985-09-04 |
1988-03-08 |
Seymour Ehrenpreis |
Novel analgesic compositions
|
|
US4743597A
(en)
|
1986-01-27 |
1988-05-10 |
Javitt Norman B |
Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
|
|
US4971960A
(en)
|
1986-03-11 |
1990-11-20 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acids
|
|
US5238686A
(en)
|
1986-03-27 |
1993-08-24 |
Kinaform Technology, Inc. |
Sustained-release pharmaceutical preparation
|
|
US4829064A
(en)
|
1987-06-08 |
1989-05-09 |
Analgesic Associates |
Cough/cold mixtures comprising non-sedating antihistamine drugs
|
|
US5891801A
(en)
|
1987-07-17 |
1999-04-06 |
Calam And Associates, Inc. |
Palatable liquid-admininstered oral medicaments for relief of discomfort and flavoring combinations therefor
|
|
US5011688A
(en)
|
1989-02-02 |
1991-04-30 |
Calam Henry D |
Liquid composition for the relief of premenstrual and menstrual discomforts
|
|
US5468482A
(en)
|
1987-07-17 |
1995-11-21 |
Calam & Associates, Inc. |
Palatable orally administered liquid medicaments for relief of discomfort and flavoring combinations therefor
|
|
US4822781A
(en)
|
1987-10-08 |
1989-04-18 |
American Home Products |
Substituted-8-alkenyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acids
|
|
US6127352A
(en)
|
1988-02-01 |
2000-10-03 |
Uribe; Jose R. |
Pharmaceutical compositions with analgesics containing codeine
|
|
US4971785A
(en)
|
1988-03-14 |
1990-11-20 |
Spectrum Consumer Products Co., Inc. |
Non-alcoholic delivery system for orally ingestible active ingredients
|
|
US4990535A
(en)
|
1989-05-03 |
1991-02-05 |
Schering Corporation |
Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
|
|
US5036097A
(en)
|
1989-10-17 |
1991-07-30 |
Oklahoma Medical Research Foundation |
Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
|
|
US5204118A
(en)
|
1989-11-02 |
1993-04-20 |
Mcneil-Ppc, Inc. |
Pharmaceutical compositions and methods for treating the symptoms of overindulgence
|
|
US5023085A
(en)
|
1989-11-29 |
1991-06-11 |
Pfizer Inc. |
Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
|
|
JPH0714872B2
(ja)
|
1990-02-06 |
1995-02-22 |
昭和薬品化工株式会社 |
シロップ剤組成物
|
|
CA2020018A1
(en)
|
1990-06-27 |
1991-12-28 |
Don L. Simmons |
Method and composition for treating the migraine complex
|
|
US5296241A
(en)
|
1991-04-03 |
1994-03-22 |
Brimberg Barnett J |
Therapeutic composition and method of using same for treatment of hangover
|
|
ATE169498T1
(de)
|
1991-09-06 |
1998-08-15 |
Mcneilab Inc |
Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
|
|
US5409709A
(en)
|
1991-11-29 |
1995-04-25 |
Lion Corporation |
Antipyretic analgesic preparation containing ibuprofen
|
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
US5322689A
(en)
|
1992-03-10 |
1994-06-21 |
The Procter & Gamble Company |
Topical aromatic releasing compositions
|
|
US5510340A
(en)
|
1992-06-12 |
1996-04-23 |
Sri International |
Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
|
|
US5306711A
(en)
|
1992-06-24 |
1994-04-26 |
Georgetown University |
Organ preservative solution
|
|
US5371077A
(en)
|
1992-08-03 |
1994-12-06 |
William Marsh Rice University |
Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them
|
|
US6303632B1
(en)
|
1992-09-03 |
2001-10-16 |
Sepracor Inc. |
Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients
|
|
US5474757A
(en)
|
1992-10-16 |
1995-12-12 |
Rutgers University |
Prevention of acetaminophen overdose toxicity with organosulfur compounds
|
|
US5260340A
(en)
|
1992-11-19 |
1993-11-09 |
Baranowitz Steven A |
Prevention and amelioration of acetaminophen toxicity with beta-carotene
|
|
US5724957A
(en)
|
1993-01-29 |
1998-03-10 |
Aradigm Corporation |
Intrapulmonary delivery of narcotics
|
|
US5599659A
(en)
*
|
1993-03-11 |
1997-02-04 |
Breonics, Inc. |
Preservation solution for ex vivo, warm preservation of tissues, explants,organs and vascular endothelial cells comprising retinal-derived fibroblast growth factor, cyclodextrin and chondroitin sulfate
|
|
US5409944A
(en)
|
1993-03-12 |
1995-04-25 |
Merck Frosst Canada, Inc. |
Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
|
|
JPH08509725A
(ja)
|
1993-04-30 |
1996-10-15 |
ザ、プロクター、エンド、ギャンブル、カンパニー |
コートされた医薬組成物
|
|
US5466865A
(en)
|
1993-07-02 |
1995-11-14 |
Ibah, Inc. |
Neomorphic ibuprofen and methods of using same
|
|
US5587368A
(en)
|
1993-11-30 |
1996-12-24 |
New York University |
Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury
|
|
GB9403857D0
(en)
|
1994-03-01 |
1994-04-20 |
Scotia Holdings Plc |
Fatty acid derivatives
|
|
US5458879A
(en)
|
1994-03-03 |
1995-10-17 |
The Procter & Gamble Company |
Oral vehicle compositions
|
|
US6077533A
(en)
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
|
US6482831B1
(en)
|
1994-06-16 |
2002-11-19 |
Entropin, Inc. |
Covalently coupled benzoylecgonine, egconine and ecgonidine derivatives
|
|
US5612061A
(en)
|
1994-10-14 |
1997-03-18 |
Rabkin; Simon W. |
Composition and method for the treatment of premenstrual syndrome
|
|
JP3828603B2
(ja)
*
|
1994-12-26 |
2006-10-04 |
株式会社日清製粉グループ本社 |
ピロリジノン誘導体を含有する医薬組成物
|
|
US5538959A
(en)
|
1995-01-26 |
1996-07-23 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
US5639475A
(en)
|
1995-02-03 |
1997-06-17 |
Eurand America, Incorporated |
Effervescent microcapsules
|
|
US5703073A
(en)
|
1995-04-19 |
1997-12-30 |
Nitromed, Inc. |
Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
|
|
US5654334A
(en)
|
1995-06-23 |
1997-08-05 |
Oklahoma Medical Research Foundation |
Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
|
|
US6645953B2
(en)
|
1995-06-23 |
2003-11-11 |
Novo Nordisk A/S |
Meiosis regulating compounds
|
|
JPH11507929A
(ja)
|
1995-06-23 |
1999-07-13 |
ノボ ノルディスク アクティーゼルスカブ |
減数分裂調節化合物
|
|
US5840731A
(en)
|
1995-08-02 |
1998-11-24 |
Virginia Commonwealth University |
Pain-alleviating drug composition and method for alleviating pain
|
|
JPH0971581A
(ja)
*
|
1995-09-08 |
1997-03-18 |
Nisshin Flour Milling Co Ltd |
ラクタム誘導体
|
|
US5897880A
(en)
|
1995-09-29 |
1999-04-27 |
Lam Pharmaceuticals, Llc. |
Topical drug preparations
|
|
CN1102852C
(zh)
|
1995-11-13 |
2003-03-12 |
皮特迈国际有限公司 |
含一氧化二氮的止痛药、消炎药和解热药的给药介质及含有这样的介质和药物的药物组合物
|
|
US6391337B2
(en)
|
1995-11-15 |
2002-05-21 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
|
US6852336B2
(en)
|
1995-11-15 |
2005-02-08 |
J. Rettenmaier & Soehne Gmbh + Co. Kg |
Directly compressible high load acetaminophen formulations
|
|
US5733578A
(en)
|
1995-11-15 |
1998-03-31 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
|
US6214386B1
(en)
|
1995-11-22 |
2001-04-10 |
Recordati, S.A. |
Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
|
|
AU1128297A
(en)
|
1995-12-06 |
1997-06-27 |
Eli Lilly And Company |
Composition for treating pain
|
|
US5773031A
(en)
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
|
CZ296263B6
(cs)
|
1996-03-25 |
2006-02-15 |
Eli Lilly And Company |
Farmaceutická kompozice pro lécení bolesti a jejípouzití
|
|
AU2587297A
(en)
|
1996-03-25 |
1997-10-17 |
Eli Lilly And Company |
Method for treating pain
|
|
US5837729A
(en)
|
1996-04-26 |
1998-11-17 |
Metatron, Inc. |
Methods for treating and preventing HIV infection using acetaminophen and derivatives thereof
|
|
US5739139A
(en)
|
1996-06-20 |
1998-04-14 |
Mcneil-Ppc, Inc. |
Acetaminophen and dimenhydrinate analgesics
|
|
JPH1072421A
(ja)
*
|
1996-07-02 |
1998-03-17 |
Nisshin Flour Milling Co Ltd |
イミド誘導体
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
FR2751875B1
(fr)
|
1996-08-05 |
1998-12-24 |
Scr Newpharm |
Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
|
|
US5872145A
(en)
|
1996-08-16 |
1999-02-16 |
Pozen, Inc. |
Formulation of 5-HT agonist and NSAID for treatment of migraine
|
|
ATE293458T1
(de)
|
1996-08-23 |
2005-05-15 |
Algos Pharm Corp |
Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
|
|
US5919826A
(en)
|
1996-10-24 |
1999-07-06 |
Algos Pharmaceutical Corporation |
Method of alleviating pain
|
|
US6077539A
(en)
|
1996-11-12 |
2000-06-20 |
Pozen, Inc. |
Treatment of migraine headache
|
|
US5776462A
(en)
|
1996-12-10 |
1998-07-07 |
Sage R&D, A Partnership |
Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat
|
|
CA2650204A1
(en)
|
1996-12-31 |
1998-07-09 |
Harry B. Demopoulos |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
WO1998032434A1
(en)
|
1997-01-29 |
1998-07-30 |
Chong Kun Dang Corp. |
New analgesic composition
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
US5891477A
(en)
|
1997-03-28 |
1999-04-06 |
Biohybrid Technologies, Inc. |
Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device
|
|
US5972916A
(en)
|
1997-07-14 |
1999-10-26 |
Bristol-Myers Squibb Company |
Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
|
|
US6077530A
(en)
|
1997-07-28 |
2000-06-20 |
Weinstein; Robert |
Analgesic dosage units for coordinated administration
|
|
GB2328443B
(en)
|
1997-08-21 |
2001-09-05 |
Reckitt & Colmann Prod Ltd |
In situ formation of pharmaceutically acceptable polymeric material
|
|
US5942530A
(en)
|
1997-08-28 |
1999-08-24 |
Eli Lilly And Company |
Method for treating pain
|
|
US8409846B2
(en)
|
1997-09-23 |
2013-04-02 |
The United States Of America As Represented By The Department Of Veteran Affairs |
Compositions, methods and devices for maintaining an organ
|
|
US5965167A
(en)
|
1997-10-07 |
1999-10-12 |
Sanghvi; Pradeepkumar P. |
Dosage units
|
|
US6162647A
(en)
|
1997-10-14 |
2000-12-19 |
Stephens; James Matthew |
Method for removing interfering substances from a urine sample using a chemical oxidant
|
|
US20030153541A1
(en)
|
1997-10-31 |
2003-08-14 |
Robert Dudley |
Novel anticholesterol compositions and method for using same
|
|
ES2412409T3
(es)
|
1997-12-22 |
2013-07-11 |
Euro-Celtique S.A. |
Forma farmacéutica para dosificación oral que comprende una combinación de un agonista opiáceo y un antagonista opiáceo
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
US6413512B1
(en)
|
1998-02-13 |
2002-07-02 |
National Enzyme Company |
Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6007841A
(en)
|
1998-03-13 |
1999-12-28 |
Algos Pharmaceutical Corporation |
Analgesic composition and method for treating pain
|
|
US6242493B1
(en)
|
1998-03-13 |
2001-06-05 |
Merck Frosst Canada & Co. |
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
|
|
US6054451A
(en)
|
1998-04-21 |
2000-04-25 |
Algos Pharmaceutical Corporation |
Analgesic composition and method for alleviating pain
|
|
IL139241A0
(en)
|
1998-05-13 |
2001-11-25 |
Novo Nordisk As |
Meiosis regulating compounds
|
|
CA2331962A1
(en)
|
1998-05-13 |
1999-11-18 |
Novo Nordisk A/S |
Meiosis regulating compounds
|
|
US6126967A
(en)
|
1998-09-03 |
2000-10-03 |
Ascent Pediatrics |
Extended release acetaminophen particles
|
|
US6254891B1
(en)
|
1998-09-03 |
2001-07-03 |
Ascent Pediatrics, Inc. |
Extended release acetaminophen
|
|
US6485747B1
(en)
|
1998-10-30 |
2002-11-26 |
Monsanto Company |
Coated active tablet(s)
|
|
WO2000028980A2
(en)
|
1998-11-13 |
2000-05-25 |
Eli Lilly And Company |
Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
|
|
US6586023B1
(en)
|
1998-12-15 |
2003-07-01 |
Wm. Wrigley Jr. Company |
Process for controlling release of active agents from a chewing gum coating and product thereof
|
|
US6627234B1
(en)
|
1998-12-15 |
2003-09-30 |
Wm. Wrigley Jr. Company |
Method of producing active agent coated chewing gum products
|
|
US6139861A
(en)
|
1999-01-14 |
2000-10-31 |
Friedman; Mark |
Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache facial pain, and cervical-muscle spasm
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6383527B1
(en)
|
1999-03-04 |
2002-05-07 |
Nps Pharmaceuticals, Inc. |
Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID
|
|
US6365338B1
(en)
|
1999-04-27 |
2002-04-02 |
David A. Bull |
Organ preservative solution containing trehalose, anti-oxidant, cations and an energy source
|
|
KR20020028876A
(ko)
|
1999-04-30 |
2002-04-17 |
추후제출 |
스테로이드 유도체
|
|
US20060025393A1
(en)
|
1999-04-30 |
2006-02-02 |
Shutsung Liao |
Steroid derivatives
|
|
US6383515B2
(en)
|
1999-05-28 |
2002-05-07 |
Sawyer Maryjean |
Solvent system for enhancing solubility
|
|
US6566361B2
(en)
|
1999-06-30 |
2003-05-20 |
Laboratories, Upsa |
Azapirone pain treatment
|
|
FR2795645B1
(fr)
|
1999-06-30 |
2001-09-21 |
Union Pharma Scient Appl |
Nouvelle association pharmaceutique a activite analgesique
|
|
CN1360554A
(zh)
|
1999-07-14 |
2002-07-24 |
可口可乐公司 |
能通气的促销物隔腔
|
|
US6642243B1
(en)
|
1999-07-22 |
2003-11-04 |
Ashkan Imanzahrai |
Migraine medicine and method for treating same
|
|
AU1291901A
(en)
|
1999-09-01 |
2001-03-26 |
University Of British Columbia, The |
Compositions and methods for modulating hdl cholesterol and triglyceride levels
|
|
US6544548B1
(en)
|
1999-09-13 |
2003-04-08 |
Keraplast Technologies, Ltd. |
Keratin-based powders and hydrogel for pharmaceutical applications
|
|
AU776831B2
(en)
|
1999-09-14 |
2004-09-23 |
Merck Frosst Canada Ltd. |
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
|
|
AU772841B2
(en)
|
1999-09-14 |
2004-05-06 |
Merck Frosst Canada Ltd. |
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
|
|
US6524623B1
(en)
|
1999-11-12 |
2003-02-25 |
Milton Hodosh |
Therapeutic compositions and methods of use thereof
|
|
KR100416242B1
(ko)
|
1999-12-22 |
2004-01-31 |
주식회사 삼양사 |
약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
|
|
US6492334B1
(en)
|
1999-12-30 |
2002-12-10 |
Robert James Generale |
Tri-compound analgesic for treating inflammation and pain
|
|
JP4018312B2
(ja)
|
2000-02-21 |
2007-12-05 |
株式会社ルネサステクノロジ |
無線通信装置
|
|
US6787164B2
(en)
|
2000-02-23 |
2004-09-07 |
Bioselect Innovations, Inc. |
Composition and method for treating the effects of diseases and maladies
|
|
US6841544B2
(en)
|
2000-02-23 |
2005-01-11 |
Bioselect Innovations, Inc. |
Composition and method for treating the effects of diseases and maladies
|
|
US7611830B2
(en)
|
2000-04-10 |
2009-11-03 |
The United States Of America As Represented By The Department Of Veteran's Affairs |
Device to lavage a blood vessel
|
|
AU2001258677A1
(en)
|
2000-05-22 |
2001-12-03 |
Dr. Reddy's Research Foundation |
Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
|
|
US6306842B1
(en)
|
2000-06-02 |
2001-10-23 |
Medinox, Inc. |
Protected forms of a combination of pharmacologically active agents and uses therefor
|
|
US6833362B2
(en)
|
2000-06-12 |
2004-12-21 |
Ward Beryl Bowen, Jr. |
Method and composition for the accelerated in vivo removal of ethanol
|
|
US6429223B1
(en)
|
2000-06-23 |
2002-08-06 |
Medinox, Inc. |
Modified forms of pharmacologically active agents and uses therefor
|
|
US6355666B1
(en)
|
2000-06-23 |
2002-03-12 |
Medinox, Inc. |
Protected forms of pharmacologically active agents and uses therefor
|
|
US6740333B2
(en)
|
2000-07-07 |
2004-05-25 |
Anestic Aps |
Suppository and composition comprising at least one polyethylene glycol
|
|
AU2001279073B2
(en)
|
2000-07-28 |
2006-08-24 |
Christopher J. Murphy |
Transplant media
|
|
US6225295B1
(en)
|
2000-09-27 |
2001-05-01 |
Frederick H. Hausheer |
Method of treating acetaminophen overdose
|
|
US6924273B2
(en)
|
2000-10-03 |
2005-08-02 |
Scott W. Pierce |
Chondroprotective/restorative compositions and methods of use thereof
|
|
US6391886B1
(en)
|
2000-12-04 |
2002-05-21 |
The Procter & Gamble Company |
Oral compositions having improved consumer aesthetics
|
|
US6440983B1
(en)
|
2000-12-21 |
2002-08-27 |
Mary Theresa Frank-Kollman |
Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
|
|
CA2438221A1
(en)
|
2001-02-08 |
2002-08-15 |
The University Of Chicago |
Steroidal derivatives
|
|
US20020164310A1
(en)
|
2001-03-02 |
2002-11-07 |
Mgvs Ltd. |
Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
|
|
US6566401B2
(en)
|
2001-03-30 |
2003-05-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
|
|
US6593331B2
(en)
|
2001-04-17 |
2003-07-15 |
Laboratories Upsa |
Method for treatment of pain
|
|
US6622856B2
(en)
|
2001-04-25 |
2003-09-23 |
Johnson & Johnson Consumer Companies, Inc. |
Relief kit
|
|
WO2002090375A2
(en)
|
2001-05-03 |
2002-11-14 |
The University Of Chicago |
Liver x receptor agonists
|
|
US20070197484A1
(en)
|
2001-05-03 |
2007-08-23 |
Ching Song |
Method of treating disorder related to high cholesterol concentration
|
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
|
IL159129A0
(en)
|
2001-06-01 |
2004-05-12 |
Pozen Inc |
PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
|
|
US6475526B1
(en)
|
2001-06-05 |
2002-11-05 |
Jeffrey B. Smith |
Zinc containing compositions for anti-viral use
|
|
US6613346B2
(en)
|
2001-06-28 |
2003-09-02 |
Wm. Wrigley, Jr. Company |
Chewable product including active ingredient
|
|
US6602518B2
(en)
|
2001-06-28 |
2003-08-05 |
Wm. Wrigley Jr. Company |
Chewable product including active ingredient
|
|
WO2003039480A2
(en)
|
2001-11-08 |
2003-05-15 |
The University Of Chicago |
Method of treating disorder related to high cholesterol concentration
|
|
US6569439B1
(en)
|
2001-11-13 |
2003-05-27 |
Noville Inc. |
Process for making personal care compositions comprising titanium dioxide and personal care compositions made by the process
|
|
US6509380B1
(en)
|
2001-12-14 |
2003-01-21 |
Marshall University Research Corporation |
Method of treating iron overload with acetaminophen
|
|
US6828328B1
(en)
|
2002-03-01 |
2004-12-07 |
Ucb S.A. |
Analgesic combination of muscarinic agonists
|
|
JP4570877B2
(ja)
|
2002-03-28 |
2010-10-27 |
明治製菓株式会社 |
臓器保存用組成物および臓器の保存方法
|
|
DE10222561B4
(de)
|
2002-05-17 |
2009-12-10 |
Dr. Franz Köhler Chemie GmbH |
Protektive Lösung zur Verhinderung von Ischämieschäden
|
|
RU2342931C2
(ru)
|
2002-08-20 |
2009-01-10 |
Бристол-Маерс Сквибб Компани |
Состав на основе комплекса арипипразола
|
|
US6702850B1
(en)
|
2002-09-30 |
2004-03-09 |
Mediplex Corporation Korea |
Multi-coated drug-eluting stent for antithrombosis and antirestenosis
|
|
EP1475434A1
(en)
|
2003-05-09 |
2004-11-10 |
Oncoscience AG |
Method for storing tumor cells
|
|
CA2569826C
(en)
|
2004-06-30 |
2013-07-16 |
Janssen Pharmaceutica N.V. |
Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
|
|
US20060047022A1
(en)
|
2004-08-30 |
2006-03-02 |
Craig Daniel H |
Thermoplastic compositions including inorganic particulates
|
|
WO2006047022A1
(en)
|
2004-10-25 |
2006-05-04 |
Virginia Commonwealth University |
Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
|
|
US8399441B2
(en)
|
2004-10-25 |
2013-03-19 |
Virginia Commonwealth University |
Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
|
|
DE102006021181B3
(de)
|
2006-05-06 |
2007-05-03 |
Laux, Thomas, Dr. |
Zahnprothesen-Trägerimplantat
|
|
CN101134100B
(zh)
*
|
2006-09-01 |
2010-11-10 |
复旦大学 |
类固醇激素合成急性调节蛋白在制备防治脂肪肝药物中的用途
|
|
JP5120998B2
(ja)
|
2006-09-06 |
2013-01-16 |
国立大学法人 東京医科歯科大学 |
組織、細胞又は臓器の保存液
|
|
GB0625965D0
(en)
|
2006-12-23 |
2007-02-07 |
Renovo Ltd |
Medicaments for wound healing
|
|
US8831674B2
(en)
|
2007-09-27 |
2014-09-09 |
Multi-Tech Systems, Inc. |
Message server
|
|
CN101951929A
(zh)
|
2007-12-28 |
2011-01-19 |
水株式会社 |
用于治疗或预防的外用剂
|
|
CN101952281B
(zh)
*
|
2008-01-04 |
2014-04-02 |
株式会社Lg生命科学 |
具有细胞、组织及器官保存效果的吲哚及吲唑衍生物
|
|
US8329450B2
(en)
|
2008-08-01 |
2012-12-11 |
Biomedinnovations, Llc |
Methods and apparatus for organ support
|
|
WO2011035005A2
(en)
|
2009-09-16 |
2011-03-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for reducing the risk of agent-induced liver toxicity
|
|
WO2011077245A2
(en)
|
2009-12-23 |
2011-06-30 |
Fondazione Centro San Raffaele Del Monte Tabor |
Compositions
|
|
EP2902019B1
(en)
|
2010-08-04 |
2017-10-04 |
Pierrel Pharma S.R.L. |
Compositions comprising inclusion complexes of cyclodextrins with spermidine for use in oral care
|
|
KR101739816B1
(ko)
|
2010-12-01 |
2017-05-25 |
주식회사유한양행 |
레바프라잔 또는 그의 염을 함유하는 주사용 액제 조성물 또는 주사용 건조 분말
|
|
US9034859B2
(en)
|
2011-04-06 |
2015-05-19 |
Virginia Commonwealth University |
Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
|
|
US9585380B2
(en)
|
2011-09-02 |
2017-03-07 |
Temple University—Of the Commonwealth System of Higher Education |
SSAT mRNA translation repression and activation
|
|
WO2013036835A1
(en)
|
2011-09-08 |
2013-03-14 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
US8665030B2
(en)
|
2011-12-14 |
2014-03-04 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Voltage-controlled oscillator
|
|
WO2013154752A1
(en)
|
2012-04-12 |
2013-10-17 |
Virgina Commonwealth University |
A NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3β-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVER DISEASES AND ATHEROSCLEROSIS
|
|
SG11201500288QA
(en)
|
2012-07-17 |
2015-02-27 |
Univ Michigan |
Inhibitors of alpha-crystallin aggregation for the treatment for cataract
|
|
EP2842547A1
(en)
|
2013-08-27 |
2015-03-04 |
Freund Pharmatec Ltd. |
Improved fenofibrate compositions
|
|
SMT202200094T1
(it)
*
|
2013-12-24 |
2022-05-12 |
Univ Virginia Commonwealth |
Uso di solfati di colesterolo ossigenati (ocs) per il trattamento dell’insufficienza epatica acuta
|
|
US20170304321A1
(en)
|
2014-10-07 |
2017-10-26 |
Sage Therapeutics, Inc. |
Neuroactive compounds and methods of use thereof
|
|
MX376196B
(es)
|
2014-10-10 |
2025-03-07 |
Univ Virginia Commonwealth |
Sulfatos de colesterol oxigenado para terapia contra trastornos provocados por al menos uno de actividad atenuada de leptina y un trastorno del almacenamiento lipidico.
|
|
EP3328389A1
(en)
|
2015-07-27 |
2018-06-06 |
Catacore, Inc. |
Compositions for the treatment of cataracts
|
|
KR102462275B1
(ko)
|
2016-08-02 |
2022-11-01 |
듀렉트 코퍼레이션 |
산소화 콜레스테롤 술페이트, 및 폴리알킬렌 글리콜, 카르복시메틸 셀룰로오스 및 폴리옥실글리세리드 중 적어도 하나를 포함하는 조성물
|
|
WO2018026781A1
(en)
|
2016-08-02 |
2018-02-08 |
Virginia Commonwealth University |
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
|
|
JP2019524774A
(ja)
|
2016-08-02 |
2019-09-05 |
ヴァージニア コモンウェルス ユニバーシティ |
炎症性皮膚疾患及び皮膚病変を処置するための酸素化コレステロール硫酸（ｏｃｓ）の使用
|